PWLP
BIIB icon

Prio Wealth Limited Partnership’s Biogen BIIB Stock Holding History

Prio Wealth Limited Partnership’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-764
Closed -$216K – 273
2021
Q3 		$216K Hold
764
– – 0.01% 262
2021
Q2 		$265K Buy
+764
New +$231K 0.01% 247
2020
Q2 		– Sell
-640
Closed -$202K – 253
2020
Q1 		$202K Sell
640
-34
-5% -$10.3K 0.01% 226
2019
Q4 		$200K Buy
+674
New +$187K 0.01% 255
2019
Q1 		– Sell
-737
Closed -$221K – 240
2018
Q4 		$221K Buy
737
+100
+16% +$31.9K 0.01% 210
2018
Q3 		$225K Sell
637
-194
-23% -$66.8K 0.01% 226
2018
Q2 		$241K Buy
831
+2
+0.2% +$562 0.01% 221
2018
Q1 		$226K Sell
829
-14
-2% -$4.35K 0.01% 224
2017
Q4 		$268K Hold
843
– – 0.01% 210
2017
Q3 		$263K Hold
843
– – 0.01% 209
2017
Q2 		$228K Buy
+843
New +$223K 0.01% 225
2016
Q4 		– Sell
-1,360
Closed -$425K – 241
2016
Q3 		$425K Hold
1,360
– – 0.02% 184
2016
Q2 		$328K Hold
1,360
– – 0.02% 202
2016
Q1 		$354K Buy
1,360
+5
+0.4% +$1.32K 0.02% 191
2015
Q4 		$415K Hold
1,355
– – 0.02% 186
2015
Q3 		$395K Hold
1,355
– – 0.02% 189
2015
Q2 		$547K Buy
1,355
+20
+1% +$8.03K 0.03% 174
2015
Q1 		$563K Hold
1,335
– – 0.03% 175
2014
Q4 		$453K Buy
1,335
+20
+2% +$6.47K 0.02% 183
2014
Q3 		$435K Sell
1,315
-25
-2% -$8.24K 0.02% 182
2014
Q2 		$422K Buy
1,340
+20
+2% +$6.02K 0.02% 189
2014
Q1 		$403K Sell
1,320
-55
-4% -$17.5K 0.02% 191
2013
Q4 		$384K Buy
1,375
+120
+10% +$31K 0.02% 194
2013
Q3 		$302K Hold
1,255
– – 0.02% 210
2013
Q2 		$270K Buy
+1,255
New +$268K 0.02% 214

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Prio Wealth Limited Partnership's BIIB Position: Q4 2021 in Review

Prio Wealth Limited Partnership sold out of Biogen (BIIB) in Q4 2021, closing a stake of 764 shares — an estimated $216K sold.

Prio Wealth Limited Partnership first reported a position in BIIB in Q2 2013 and held it in 25 quarters. The position peaked at $563K in Q1 2015. 1,009 funds tracked by Wall St. Rank hold BIIB as of Q4 2021.

  • Prio Wealth Limited Partnership reported no remaining Biogen position as of Q4 2021 after selling out during the quarter.
  • Prio Wealth Limited Partnership sold 764 Biogen shares in Q4 2021, an estimated $216K.
  • Prio Wealth Limited Partnership first reported a position in Biogen in Q2 2013 and held it in 25 quarters.
  • Prio Wealth Limited Partnership's Biogen position peaked at $563K in Q1 2015.
  • 1,009 funds tracked by Wall St. Rank held Biogen as of Q4 2021.

Based on Prio Wealth Limited Partnership's 13F filing for Q4 2021, filed 17 Feb 2022.